ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/20/2024
Back to search
Official data from USPTO
N NORAC PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/20/2024
Trademark type
Combined
Nice classes
39, 40, 42
Filing date
02/28/2002
Registration date
02/04/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/22/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2000-12-00
First use in commerce
2000-12-00
Drawing code
3
Owner type
16
Owner location
AZUSA, CA, US
Examiner
BROWN, BARBARA TROFFKIN
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
S & B PHARMA, LLC
S & B PHARMA, INC.
Norac, Inc.
Representatives
Christopher Kelly WILEY REIN LLP
Technical classification
Nice Classes
Class 39Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Storage of pharmaceuticals for others
Class 40
Providing custom chemical synthesis and separation services for othersmanufacture of pharmaceuticals for others
Class 42
Research and testing services in the fields of chemicals and pharmaceuticals and chemical analysis of pharmaceuticals for others
Publications
History of USPTO decisions and trademark events.
33 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/22/2023
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/22/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/22/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/22/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
02/06/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/04/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/13/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/13/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/13/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/17/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/06/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/06/2014
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/06/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/06/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/06/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
03/21/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/16/2008
PLGL
ASSIGNED TO PARALEGAL
08/06/2008
E815
TEAS SECTION 8 & 15 RECEIVED
07/30/2008
CFIT
CASE FILE IN TICRS
02/04/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2003
PAPER RECEIVED
11/29/2002
PUBO
PUBLISHED FOR OPPOSITION
11/12/2002
NPUB
NOTICE OF PUBLICATION
10/23/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/22/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2002
PAPER RECEIVED
07/19/2002
CNRT
NON-FINAL ACTION MAILED
06/12/2002
DOCK
ASSIGNED TO EXAMINER
06/06/2002
Continuous trademark protection
Get notified about every new filing that threatens N NORAC PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.